Jian Fang

机构：Kunming University of Science and Technology, Wenzhou Medical University, Soochow University, Gaochun People's Hospital, Ministry of Education · ORCID：0000-0002-1077-3686

发表论文 183 篇 · 总被引 5732 次 · h-index 27

代表论文

• Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy as first-line treatment for advanced squamous non-small-cell lung cancer (HARMONi-6): a randomised, double-blind, phase 3 trial (2025 · The Lancet · 被引 33)
• Rezivertinib versus gefitinib as first-line therapy for patients with EGFR-mutated locally advanced or metastatic non-small-cell lung cancer (REZOR): a multicentre, double-blind, randomised, phase 3 study (2025 · The Lancet Respiratory Medicine · 被引 17)
• Immune checkpoint inhibitor-related myocarditis in patients with lung cancer (2025 · BMC Cancer · 被引 7)
• Sacituzumab tirumotecan (sac-TMT) in combination with tagitanlimab (anti-PD-L1) in first-line (1L) advanced non-small-cell lung cancer (NSCLC): Non-squamous cohort from the phase II OptiTROP-Lung01 study. (2025 · Journal of Clinical Oncology · 被引 6)
• Efficacy and safety of finotonlimab plus docetaxel vs. docetaxel in previously treated advanced squamous cell non-small-cell lung cancer: a randomized, double-blinded, phase III trial (2025 · Translational Lung Cancer Research · 被引 5)
• Exosomes miR‐369‐3p Alleviates Early Brain Injury After Subarachnoid Hemorrhage by Promoting Ferroptosis of M1 Microglia via Inhibiting iNOS/GPX4 Axis (2025 · Brain and Behavior · 被引 3)